<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 11 (filtered)">
<title>Hawaii Revised Statutes</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Courier;
	panose-1:2 7 4 9 2 2 5 2 4 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
h1
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Courier New";}
h3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Courier New";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.RegularParagraphs, li.RegularParagraphs, div.RegularParagraphs
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.1Paragraph, li.1Paragraph, div.1Paragraph
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	margin-bottom:.0001pt;
	text-indent:-1.0in;
	font-size:12.0pt;
	font-family:"Courier New";}
p.1ParagraphContd, li.1ParagraphContd, div.1ParagraphContd
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	margin-bottom:.0001pt;
	text-indent:-1.0in;
	line-height:200%;
	font-size:12.0pt;
	font-family:"Courier New";}
p.ASubparagraph, li.ASubparagraph, div.ASubparagraph
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.5in;
	margin-bottom:.0001pt;
	text-indent:-1.5in;
	font-size:12.0pt;
	font-family:"Courier New";}
p.ASubparagraphContd, li.ASubparagraphContd, div.ASubparagraphContd
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.5in;
	margin-bottom:.0001pt;
	text-indent:-1.5in;
	line-height:200%;
	font-size:12.0pt;
	font-family:"Courier New";}
p.iClause, li.iClause, div.iClause
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-indent:-2.0in;
	font-size:12.0pt;
	font-family:"Courier New";}
p.XNotesHeading, li.XNotesHeading, div.XNotesHeading
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Courier New";
	font-weight:bold;}
p.XNotes, li.XNotes, div.XNotes
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.Constitution, li.Constitution, div.Constitution
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.aSubsection, li.aSubsection, div.aSubsection
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.Style1, li.Style1, div.Style1
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.1Paragraphunderscored, li.1Paragraphunderscored, div.1Paragraphunderscored
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	margin-bottom:.0001pt;
	text-indent:-1.0in;
	line-height:200%;
	font-size:12.0pt;
	font-family:"Courier New";
	text-decoration:underline;}
 /* Page Definitions */
 @page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.0in 1.0in 1.0in;}
div.Section1
	{page:Section1;}
-->
</style>

</head>

<body lang=EN-US>

<div class=Section1>

<p class=RegularParagraphs>     <b>§329-16  Schedule II.</b>  (a)  The
controlled substances listed in this section are included in schedule II.</p>

<p class=RegularParagraphs>     (b)  Any of the following substances, except
those narcotic drugs listed in other schedules, whether produced directly or
indirectly by extraction from substances of vegetable origin, or independently
by means of chemical synthesis, or by combination of extraction and chemical
synthesis:</p>

<p class=1Paragraph>     (1)  Opium and opiate, and any salt, compound,
derivative, or preparation of opium or opiate, including the following:</p>

<p class=ASubparagraph>         (A)  Raw opium;</p>

<p class=ASubparagraph>         (B)  Opium extracts;</p>

<p class=ASubparagraph>         (C)  Opium fluid;</p>

<p class=ASubparagraph>         (D)  Powdered opium;</p>

<p class=ASubparagraph>         (E)  Granulated opium;</p>

<p class=ASubparagraph>         (F)  Codeine;</p>

<p class=ASubparagraph>         (G)  Ethylmorphine;</p>

<p class=ASubparagraph>         (H)  Etorphine hydrochloride;</p>

<p class=ASubparagraph>         (I)  Hydrocodone;</p>

<p class=ASubparagraph>         (J)  Hydromorphone;</p>

<p class=ASubparagraph>         (K)  Metopon;</p>

<p class=ASubparagraph>         (L)  Morphine;</p>

<p class=ASubparagraph>         (M)  Oxycodone;</p>

<p class=ASubparagraph>         (N)  Oxymorphone; and</p>

<p class=ASubparagraph>         (O)  Thebaine;</p>

<p class=1Paragraph>     (2)  Any salt, compound, isomer, derivative, or
preparation thereof which is chemically equivalent or identical with any of the
substances referred to in paragraph (1), but not including the isoquinoline
alkaloids of opium;</p>

<p class=1Paragraph style='margin-left:1.5in'>(3)  Opium poppy and poppy straw;</p>

<p class=1Paragraph style='text-indent:-.5in'>(4)  Coca leaves and any salt,
compound, derivative, or preparation of coca leaves, and any salt, compound,
derivative, or preparation thereof which is chemically equivalent or identical
with any of these substances, but not including decocanized coca leaves or
extractions which do not contain cocaine or ecgonine; cocaine or any salt or
isomer thereof; and</p>

<p class=1Paragraphunderscored style='line-height:normal'><span
style='text-decoration:none'>     (5)  Concentrate of poppy straw (the crude
extract of poppy straw in either liquid, solid, or powder form that contains
the phenanthrene alkaloids of the opium poppy).</span></p>

<p class=RegularParagraphs>     (c)  Any of the following opiates, including
their isomers, esters, ethers, salts, and salts of isomers, whenever the
existence of these isomers, esters, ethers, and salts is possible within the
specific chemical designation:</p>

<p class=1Paragraph>     (1)  Alfentanil;</p>

<p class=1Paragraph>     (2)  Alphaprodine;</p>

<p class=1Paragraph>     (3)  Anileridine;</p>

<p class=1Paragraph>     (4)  Bezitramide;</p>

<p class=1Paragraph>     (5)  Bulk Dextropropoxyphene (nondosage form);</p>

<p class=1Paragraph>     (6)  Carfentanil;</p>

<p class=1Paragraph>     (7)  Dihydrocodeine;</p>

<p class=1Paragraph>     (8)  Diphenoxylate;</p>

<p class=1Paragraph>     (9)  Fentanyl;</p>

<p class=1Paragraph>    (10)  Isomethadone;</p>

<p class=1Paragraph>    (11)  Levo-alphacetylmethadol (LAAM);</p>

<p class=1Paragraph>    (12)  Levomethorphan;</p>

<p class=1Paragraph>    (13)  Levorphanol;</p>

<p class=1Paragraph>    (14)  Metazocine;</p>

<p class=1Paragraph>    (15)  Methadone;</p>

<p class=1Paragraph>    (16)  Methadone-Intermediate,
4-cyano-2-dimethylamino-4, 4-diphenyl butane;</p>

<p class=1Paragraph>    (17)  Moramide-Intermediate, 2-methyl-3-morpholino-1,
1-diphenyl-propane-carboxylic acid;</p>

<p class=1Paragraph>    (18)  Pethidine (Meperidine);</p>

<p class=1Paragraph>    (19)  Pethidine-Intermediate-A,
4-cyano-1-methyl-4-phenylpiperidine;</p>

<p class=1Paragraph>    (20)  Pethidine-Intermediate-B,
ethyl-4-phenylpiperidine-4-carboxylate;</p>

<p class=1Paragraph>    (21)  Pethidine-Intermediate-C,
1-methyl-4-phenylpiperidine-4-carboxylic acid;</p>

<p class=1Paragraph>    (22)  Phenazocine;</p>

<p class=1Paragraph>    (23)  Piminodine;</p>

<p class=1Paragraph>    (24)  Racemethorphan;</p>

<p class=1Paragraph>    (25)  Racemorphan;</p>

<p class=1Paragraph>    (26)  Remifentanil; and</p>

<p class=1Paragraph>    (27)  Sufentanil.</p>

<p class=RegularParagraphs>     (d)  Depressants.  Unless specifically excepted
or unless listed in another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following substances having a
depressant effect on the central nervous system:</p>

<p class=1Paragraph>     (1)  Amobarbital;</p>

<p class=1Paragraph>     (2)  Glutethimide;</p>

<p class=1Paragraph>     (3)  Pentobarbital;</p>

<p class=1Paragraph>     (4)  Phencyclidine;</p>

<p class=1Paragraph>     (5)  Phencyclidine immediate precursors:</p>

<p class=ASubparagraph>         (A)  1-phenycyclohexylamine;</p>

<p class=ASubparagraph>         (B)  1-piperidinocyclohexanecarbonitrile (PCC);
and</p>

<p class=1Paragraph>     (6)  Secobarbital.</p>

<p class=RegularParagraphs>     (e)  Stimulants.  Any material, compound,
mixture, or preparation which contains any quantity of the following substances
having a danger or probable danger associated with a stimulant effect on the
central nervous system:</p>

<p class=1Paragraph>     (1)  Amphetamine, its salts, optical isomers, and
salts of its optical isomers;</p>

<p class=1Paragraph>     (2)  Any substance which contains any quantity of
methamphetamine, including its salts, isomers, and salts of isomers.</p>

<p class=RegularParagraphs>     (f)  Any material, compound, mixture, or
preparation which contains any quantity of the following substances having a
degree of danger or probable danger associated with a stimulant effect on the
central nervous system:</p>

<p class=1Paragraph>     (1)  Phenmetrazine and its salts;</p>

<p class=1Paragraph>     (2)  Phenylacetone (P2P);</p>

<p class=1Paragraph>     (3)  Methylphenidate.</p>

<p class=RegularParagraphs>     (g)  Hallucinogenic substances, unless listed
in another schedule, shall include Nabilone. [L 1972, c 10, pt of §1 and am c
114, §2(2); am L 1974, c 217, §2; am L 1975, c 26, §1; am L 1978, c 68, §3; am
L 1979, c 194, §2; am L 1981, c 125, §§1, 2; am L 1984, c 166, §2; am L 1985, c
150, §2; am L 1987, c 203, §1; am L 1988, c 59, §2; am L 1990, c 138, §4; am L
1991, c 159, §7; am L 1995, c 122, §2; am L 1997, c 356, §2; am L 2000, c 98,
§§2, 3; am L 2001, c 203, §3; am L 2002, c 165, §1; am L 2003, c 151, §3]</p>

<p class=RegularParagraphs>&nbsp;</p>

<p class=XNotesHeading>Case Notes</p>

<p class=XNotes>&nbsp;</p>

<p class=XNotes>  Method used to prove that capsules of methaqualone
hydrochloride contained methaqualone accepted as evidence.  1 H. App. 31, 613
P.2d 919.</p>

<p class=XNotes>&nbsp;</p>

</div>

</body>

</html>
<center><table border="0" width="90%"><tr>
<td align="left"><a href="/hrscurrent/Vol06_Ch0321-0344/HRS0329/HRS_0329-0015.HTM">Previous</a></td>
<td align="center"><a href=/hrscurrent/Vol06_Ch0321-0344>Vol06_Ch0321-0344</a></td>
<td align="right"><a href="/hrscurrent/Vol06_Ch0321-0344/HRS0329/HRS_0329-0017.HTM">Next</a></td>
</tr></table></center>
